Flatiron Health Sustainability Profile
Flatiron Health, a leading healthcare technology company headquartered in the United States, was founded in 2012 with a mission to improve cancer care through data-driven insights. The company operates primarily in the oncology sector, focusing on harnessing real-world evidence to enhance treatment outcomes and streamline clinical research. Flatiron Health's core offerings include its electronic health record (EHR) platform, which uniquely integrates clinical data with advanced analytics, enabling healthcare providers and researchers to make informed decisions. Notable achievements include partnerships with major pharmaceutical companies and a significant role in advancing precision medicine. With a strong market position, Flatiron Health continues to be at the forefront of transforming cancer care, leveraging technology to support both clinicians and patients in their journey through treatment.
DitchCarbon Score
How does Flatiron Health's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Flatiron Health's score of 78 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Flatiron Health, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Roche Holding AG, which may influence its climate commitments and reporting practices. Flatiron Health has not established its own reduction targets or initiatives, nor does it have specific climate pledges documented. However, it is important to note that any potential climate commitments or emissions data may be inherited from its parent company, Roche Holding AG. This relationship suggests that Flatiron Health may align with Roche's sustainability strategies and targets, although specific details on these initiatives are not provided. As a part of the healthcare industry, Flatiron Health is positioned within a sector increasingly focused on reducing carbon footprints and enhancing sustainability practices. The lack of direct emissions data highlights an opportunity for the company to develop and communicate its climate commitments more transparently in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Flatiron Health's Industry?
How Carbon Intensive is Flatiron Health's Location?
Flatiron Health's Scope 3 Categories Breakdown
Flatiron Health's Scope 3 emissions, which decreased by 8% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Flatiron Health's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Flatiron Health has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
